Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 1, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gain Therapeutics, Inc.
| 17K |
$1.22 | $20,670.00 | +6.24% | 289.63K |
Jul 1
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Gain Therapeutics, Inc.
| 54.9K |
—
|
—
| +25.21% | 272.63K |
Sep 20
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 20
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 9
| |||||||
Gain Therapeutics, Inc.
| 2.48K |
$2.58 | $6,403.56 | +1.15% | 217.73K |
May 25
| |||||||
Gain Therapeutics, Inc.
| 13.26K |
$2.79 | $37,034.48 | +6.56% | 215.25K |
May 19 - May 20
| |||||||
Gain Therapeutics, Inc.
| 4.92K |
$7.87 | $38,716.45 | +2.32% | 216.82K |
Aug 16
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Neubase Therapeutics, Inc.
| 3.88K |
$1.64 | $6,352.40 | +9.44% | 44.96K |
Mar 1 - Mar 4
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 19
| |||||||
Gain Therapeutics, Inc.
| 4.92K |
$7.87 | $38,716.45 | +2.32% | 216.82K |
Aug 16
| |||||||
Neubase Therapeutics, Inc.
| 5K |
$5.00 | $25,000.00 | +13.86% | 41.08K |
Apr 26
| |||||||
Gain Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 9
| |||||||
Neubase Therapeutics, Inc.
| 10.83K |
$6.00 | $64,998.00 | +20.44% | 63.83K |
Apr 30
| |||||||
Adma Biologics, Inc.
| 7.5K |
—
|
—
| +20.53% | 44.03K |
Feb 28
| |||||||
Neubase Therapeutics, Inc.
| 25.25K |
—
|
—
|
∞
| 25.25K |
Jul 12
| |||||||
Neubase Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 13
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Adma Biologics, Inc.
| 5.23K |
$4.78 | $24,999.40 | +16.71% | 36.53K |
Jun 8
| |||||||
Adma Biologics, Inc.
| 25K |
$2.15 | $53,750.00 | +396.83% | 31.3K |
Nov 9
| |||||||
Adma Biologics, Inc.
| 2.8K |
$2.68 | $7,504.00 | +80.00% | 6.3K |
Jul 13
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
Pharmathene, Inc
| 483.73K |
$1.85 | $895,213.18 | +116.75% | 898.05K |
Nov 22
| |||||||
Pharmathene, Inc
| 237.5K |
$1.45 | $343,625.00 | +134.32% | 414.32K |
Sep 28
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Pharmathene, Inc
|
0
|
$1.70 | -$332,338.36 |
—
| 176.82K |
Apr 13
|
Scheduled
| ||||||
Pharmathene, Inc
|
0
|
$1.98 | -$5,177.48 |
—
| 176.82K |
Apr 7 - Apr 8
|
Scheduled
| ||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 28
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 2
| |||||||
Adma Biologics, Inc.
| 3.5K |
$7.88 | $27,570.00 |
∞
| 3.5K |
Mar 13
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 30
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 11
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 29
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 12
| |||||||
Adma Biologics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 4
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.